Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Topiramate recalled?

Yes — there is an active recall. 2 ongoing FDA recalls mention Topiramate (11 total). Check the affected lots below.

Most common reason: Dissolution failure (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Topiramate. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Topiramate recalls in 2026

2 initiated in 2026, 11 in total — newest first
Class III · Low risk

Trokendi XR

Failed dissolution specifications.

Ongoing Dissolution failure Supernus Pharmaceuticals, Inc. NDC 17772-102-30 D-0833-2026
Class III · Low risk

Trokendi XR

Failed Dissolution Specifications

Ongoing Dissolution failure Supernus Pharmaceuticals, Inc. NDC 17772-101-30 D-0758-2026
Class III · Low risk

Eprontia (topiramate)

Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.

Terminated Impurity / degradation Azurity Pharmaceuticals, Inc. NDC 52652-9001-1 D-0213-2024
Class II · Moderate risk

Trokendi XR

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 17772-103-30 D-0570-2021
Class II · Moderate risk

Topiramate 25mg Tabs White/round tablets

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 47335-0707-13 D-1520-2020
Class II · Moderate risk

Trokendi XR

Superpotent Drug: Failure of assay specifications in the capsule.

Terminated Wrong potency / content Supernus Pharmaceuticals, Inc. NDC 17772-102-15 D-0112-2017
Class II · Moderate risk

Topiramate active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-936-2015
Class III · Low risk

Glenmark Topiramate Tablets

Chemical Contamination: Topiramate Tablets is being recalled due to complaints related to an off - odor. described as moldy, musty or fishy in nature.

Terminated Chemical / undeclared Glenmark Generics Inc., USA NDC 68462-110-60 D-331-2013
Class III · Low risk

Topiramate Tablets

Labeling: Label Mix-Up: A typographical error in the product form on the carton label incorrectly lists the configuration as 30 "Capsules" (3 x 10) rather than "Tablets".

Terminated Labeling / mix-up American Health Packaging NDC 68084-343-21 D-1645-2012